ArticleAmerican journal of preventive medicine2024
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
Article in American journal of preventive medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03898167 (A Randomized Controlled Trial of Mailed Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System), which is not on this map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Controlled Trial of Mailed Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System
Who cites it
16 citing papers in PubMed, 15 citations in OpenAlex.
- Insights of Vietnamese American Women on Cervical Cancer Screening and HPV Self-Sampling.Journal of racial and ethnic health disparities · 2026Article
- Cervical cancer screening preferences by sexual orientation among persons assigned female at birth.BMC women's health · 2026Article
- Acceptability of HPV self-sampling in three urban academic emergency departments.BMC public health · 2026Article
- Integrated Cervical Self-Sampling for Cytology, High-Risk Human Papillomavirus, and Sexually Transmitted Infection Testing: A Prospective Study.Diagnostics (Basel, Switzerland) · 2026Article
- Perceptions of HPV Self-Collection for Cervical Cancer Screening Among Mobile Health Program Attendees.medRxiv : the preprint server for health sciences · 2026Article
- Enhancing Cervical Cancer Screening Among Northern Thai Women: Satisfaction with Self-Collected HPV DNA Testing under the National Program.Asian Pacific journal of cancer prevention : APJCP · 2026Article
- Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening.JAMA network open · 2026Article
- Comparative performance of hrHPV testing and PAX1/ZNF671 methylation in triaging women with abnormal cytology: a study of paired urine, vaginal and cervical scrape samples.Frontiers in oncology · 2026Article
- Observational
- Preferences of High-Risk HPV-Based Cervical Cancer Screening among Transgender Men and Gender Diverse People Assigned Female at Birth: A Cross-Sectional Study at a Single Academic Center.Cancer causes & control : CCC · 2025Article
- Development and Evaluation of Innovation Scales for Mail-Based Human Papillomavirus (HPV) Self-Collection Among U.S. Low-Income Women.Nursing reports (Pavia, Italy) · 2025Article
- Group concept mapping to develop a salon-based HPV self-collection intervention.Cancer causes & control : CCC · 2025Article
- Genetic self-counselors in Tunisia: the role of health education in hemoglobinopathies prevention among high school students.Orphanet journal of rare diseases · 2025Article
- Impact of mode of offer of self-sampling to people overdue cervical screening on screening participation: a randomised controlled trial.EClinicalMedicine · 2025Article
- The levels of women's awareness, experience, acceptability and preference for Vaginal Human Papillomavirus (HPV) self-sampling in three provinces of China: a cross-sectional study.BMC women's health · 2024Article
- To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 6 institutions in 1 country.
Funding
Abstract
introductionSelf-sampling for human papillomavirus testing is increasingly recognized as a strategy to expand cervical cancer screening access and utilization. Acceptability is a key determinant of uptake. This study assesses the acceptability of and experiences with mailed self-sampling kits for human papillomavirus testing among underscreened patients in a safety net health system.
methodsA nested telephone survey was administered between 2021 and 2023 to a sample (n=272) of the 2,268 participants enrolled in the Prospective Evaluation of Self-Testing to Increase Screening trial. Trial participants include patients of a safety net health system aged 30-65 years who were not up to date on screening. Participants were asked about barriers to provider-performed screening. Kit users and nonusers were asked about their experiences.
resultsPrevalent barriers to provider-performed screening included perceived discomfort of pelvic examination (69.4%), being uncomfortable with male providers (65.4%), and embarrassment (57.0%). Among participants who reported using the mailed kit (n=164), most reported good experiences (84.8%). Most reported self-sampling as more/equally convenient (89.0%), less/equally embarrassing (99.4%), and less/equally stressful (95.7%) than provider-performed screening. Among kit nonusers (n=43), reasons for not using the kit included forgetting about it (76.7%), preferring provider-performed screening (76.7%), and fearing cancer (67.4%).
conclusionsProspective Evaluation of Self-Testing to Increase Screening trial participants generally had a positive experience with self-sampling for human papillomavirus testing. Increased comfort and reduced embarrassment/anxiety with self-sampling are relevant attributes because these were the most prevalent reported barriers to provider-performed screening. High acceptability suggests potentially high uptake when self-sampling for human papillomavirus testing receives regulatory approval and is available in safety net health systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.